NCT07477743 2026-03-17
A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combinations in Advanced Solid Tumors
HC Biopharma Inc.
Phase 1 Recruiting
HC Biopharma Inc.
Nanjing Leads Biolabs Co.,Ltd
CStone Pharmaceuticals
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Risen (Suzhou) Pharma Tech Co., Ltd.
Shanghai Junshi Bioscience Co., Ltd.
Beijing Biostar Pharmaceuticals Co., Ltd.